BR112013009068A2 - supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno - Google Patents

supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno

Info

Publication number
BR112013009068A2
BR112013009068A2 BR112013009068A BR112013009068A BR112013009068A2 BR 112013009068 A2 BR112013009068 A2 BR 112013009068A2 BR 112013009068 A BR112013009068 A BR 112013009068A BR 112013009068 A BR112013009068 A BR 112013009068A BR 112013009068 A2 BR112013009068 A2 BR 112013009068A2
Authority
BR
Brazil
Prior art keywords
suppression
immune response
source material
antigen derived
unrelated antigen
Prior art date
Application number
BR112013009068A
Other languages
English (en)
Inventor
Jens Brimnes
Kaare Lund
Original Assignee
Alk Abelló As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45002474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013009068(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abelló As filed Critical Alk Abelló As
Publication of BR112013009068A2 publication Critical patent/BR112013009068A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
BR112013009068A 2010-10-15 2011-10-14 supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno BR112013009068A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39348310P 2010-10-15 2010-10-15
EP10187745 2010-10-15
EP11157869 2011-03-11
PCT/EP2011/068026 WO2012049310A1 (en) 2010-10-15 2011-10-14 Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material

Publications (1)

Publication Number Publication Date
BR112013009068A2 true BR112013009068A2 (pt) 2016-07-19

Family

ID=45002474

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013009068A BR112013009068A2 (pt) 2010-10-15 2011-10-14 supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno

Country Status (14)

Country Link
US (2) US20140010845A1 (pt)
EP (2) EP2987501A1 (pt)
JP (1) JP2013544784A (pt)
KR (1) KR20130118884A (pt)
CN (1) CN103547287A (pt)
AR (1) AR087930A1 (pt)
BR (1) BR112013009068A2 (pt)
CA (1) CA2813344A1 (pt)
EA (1) EA201390559A1 (pt)
ES (1) ES2549591T3 (pt)
HK (1) HK1188396A1 (pt)
MX (1) MX2013003817A (pt)
TW (1) TWI528971B (pt)
WO (1) WO2012049310A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201491481A1 (ru) 2012-02-07 2014-11-28 Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи Аллергены тимофеевки луговой и способы и применения для модулирования иммунного ответа
EA029009B1 (ru) * 2012-04-16 2018-01-31 Альк-Абелло А/С Применение полипептида профилина растений в неспецифической иммунотерапии аллергии
GB201209862D0 (en) 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
US9128965B1 (en) 2013-08-07 2015-09-08 Amazon Technologies, Inc. Configurable-capacity time-series tables
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
WO2015077434A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Pan pollen immunogens and methods and uses for immune response modulation
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
US10872313B2 (en) 2015-06-02 2020-12-22 ROCA Medical Ltd. Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10064936B2 (en) 2015-02-20 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160362205A1 (en) * 2015-06-02 2016-12-15 ROCA Medical Ltd. Use of autoinjector for distributing antigens to the public
US10548974B2 (en) 2015-06-02 2020-02-04 ROCA Medical Ltd. Therapeutic treatment kit for allergies based on DNA profiles
US10369215B2 (en) 2015-06-02 2019-08-06 ROCA Medical Ltd. Predilution sets for distributing antigens
US11013781B2 (en) 2015-07-01 2021-05-25 Alk-Abelló As Peptide combinations and uses thereof for treating grass allergy
EP3463449A1 (en) 2016-05-27 2019-04-10 ALK-Abelló A/S Immunogenic proteins and fragments thereof from allergenic mites
CN111465328A (zh) 2017-07-18 2020-07-28 前品牌股份有限公司 制备混合型变应原组合物的方法
KR102107056B1 (ko) 2017-09-22 2020-05-29 연세대학교 산학협력단 진드기에 대한 알레르기성 질환 진단용 조성물, 진드기에 대한 알레르기성 진단 방법, 및 진드기에 대한 알레르기성 질환을 예방 또는 치료하기 위한 조성물
US11766477B2 (en) 2019-01-23 2023-09-26 Societe Des Produits Nestle S.A. Methods for making mixed allergen compositions
CN111172311B (zh) * 2020-01-08 2023-06-30 西北民族大学 大豆核桃过敏原基因二重荧光定量pcr检测试剂盒
US20220040294A1 (en) * 2020-08-07 2022-02-10 Robert E. Coifman Administration of vaccines to sites of temporally induced cell-mediated hypersensitivity reactions, to facilitate the development of protective sensitization against infectious diseases and cancers
CN113125753B (zh) * 2021-04-16 2022-07-26 杭州浙大迪迅生物基因工程有限公司 一种用于检测尘螨组分特异性抗体的试剂盒
CN113892461A (zh) * 2021-10-28 2022-01-07 中国农业大学 小麦面筋蛋白经皮致敏小鼠模型的构建方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950700082A (ko) * 1992-02-28 1995-01-16 로버트 씨. 비숍 바이스탠더(bystander)에 의한 자가면역질환을 처치하는 방법
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
WO1999056763A1 (en) * 1998-05-07 1999-11-11 The Regents Of The University Of California Use of neglected target tissue antigens in modulation of immune responses
CA2440474A1 (en) 2001-04-05 2002-10-17 Virginia Mason Research Center Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment
JP2006517533A (ja) * 2003-01-23 2006-07-27 ロランティス リミテッド Ｎｏｔｃｈシグナル伝達経路のアクチベーターを用いる自己免疫疾患の治療
WO2004083372A2 (en) * 2003-03-21 2004-09-30 Lorantis Limited Modulators of the notch signaling pathway immobilized on particles for modifying immune responses
EP1646400B1 (en) 2003-03-21 2010-07-21 Celldex Therapeutics Limited Treatment of allergic diseases using a modulator of the notch signaling pathway
WO2005115449A1 (en) * 2004-05-28 2005-12-08 Alk-Abelló A/S Method of treating allergy and infection by eliciting an iga antibody response
JP5628473B2 (ja) * 2004-11-10 2014-11-19 アルク−アベッロ エイ／エスＡｌｋ−Ａｂｅｌｌｏ Ａ／Ｓ アレルギーワクチンの粘膜投与によるアレルギーの予防治療方法
US20070231298A1 (en) * 2006-03-31 2007-10-04 Cell Genesys, Inc. Cytokine-expressing cancer immunotherapy combinations
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung

Also Published As

Publication number Publication date
CN103547287A (zh) 2014-01-29
ES2549591T3 (es) 2015-10-29
CA2813344A1 (en) 2012-04-19
TW201306863A (zh) 2013-02-16
KR20130118884A (ko) 2013-10-30
MX2013003817A (es) 2013-05-01
WO2012049310A1 (en) 2012-04-19
EP2627355B1 (en) 2015-08-26
EA201390559A1 (ru) 2013-08-30
AR087930A1 (es) 2014-04-30
EP2627355A1 (en) 2013-08-21
EP2987501A1 (en) 2016-02-24
US20140010845A1 (en) 2014-01-09
US20120100164A1 (en) 2012-04-26
TWI528971B (zh) 2016-04-11
JP2013544784A (ja) 2013-12-19
HK1188396A1 (en) 2014-05-02

Similar Documents

Publication Publication Date Title
BR112013009068A2 (pt) supressão de uma resposta imune de hipersensibilidade com antígeno não relacionado derivado de material fonte de alérgeno
CY2017025I2 (el) Αντιδοτα αντιπηκτικων
CO6930350A2 (es) Mezclas de cemento-scm de partículas empacadas
DK3029066T3 (da) Antistoffer med modificerede isoelektriske punkter
CO7020851A2 (es) Proteínas y péptidos modificados
DK3459564T3 (da) Plasmakallikreinbindende proteiner
BR112013027076A2 (pt) cadeia biométrica de procedência
BRPI0921927A2 (pt) sensibilização de uma resposta imune
BR112014012137A2 (pt) anticorpos anti-fgfr2 e suas utilizações
DE112012000865A5 (de) Durchführungsbauteil
DK2813573T1 (da) ADAM6 mus
DK2501817T4 (da) Mus med fælles let kæde
BR112013005198A2 (pt) construção de um tecido aderente
PL2547954T3 (pl) Źródła światła przystosowane do czułości widmowej dziennych ptaków i ludzi
BR112014004902A2 (pt) peptídeos
BR112012024025A2 (pt) conjunto de sensor
BR112014013850A2 (pt) conjunto de prateleiras
EP2897455A4 (en) LIGHT SOURCES ADAPTED TO THE SPECTRAL SENSITIVITY OF TAGACTIVE BIRDS AND PEOPLE
BR112013017488A2 (pt) peptídeos imunogênicos multiméricos e monoméricos
BR112013011842A2 (pt) partículas de imunomoduladoras modificadas
BR112013024323A2 (pt) peptídeos neuroprotetores
BR112014023176A2 (pt) Métodos de produção de uma proteína recombinante
IT1398549B1 (it) Silil- derivati di polisaccaridi
EP2673292A4 (en) WHEAT ANTIGENES AND PEPTIDES FOR DIAGNOSIS OF WHEAT SENSITIVITY
BR112013009679A2 (pt) peptídeo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2483 DE 07-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.